SPM-001

N/A

Report date: 2024/10/10 17:49:35
NMEFirst In Class

Base Information

Drug NameSPM-001
Drug Alias NameSPM-001SPM001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMyeloid differentiation primary response protein MyD88 modulators
TargetsMyeloid differentiation primary response protein MyD88
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSPIMA Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesTechnology Transfer Accelerator Offices _ Satt AxlrSPIMA Therapeutics
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A